AbbVie said on Monday its newer arthritis drug Rinvoq showed superiority over the company's previous bestseller Humira in a ...
(Reuters) -AbbVie said on Monday its newer arthritis drug Rinvoq showed superiority over the company's previous bestseller ...
The label update provides an option for patients who have received at least 1 approved systemic therapy if TNF blockers are clinically inadvisable.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback